Product NDC: | 0173-0839 |
Proprietary Name: | AVANDAMET |
Non Proprietary Name: | rosiglitazone maleate and metformin hydrochloride |
Active Ingredient(s): | 500; 4 mg/1; mg/1 & nbsp; rosiglitazone maleate and metformin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0839 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021410 |
Marketing Category: | NDA |
Start Marketing Date: | 20110524 |
Package NDC: | 0173-0839-18 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0839-18) |
NDC Code | 0173-0839-18 |
Proprietary Name | AVANDAMET |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0839-18) |
Product NDC | 0173-0839 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rosiglitazone maleate and metformin hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110524 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE |
Strength Number | 500; 4 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |